protective immune responses induced by secretion of a chimeric soluble protein from a recombinant mycobacterium bovis bacillus calmette-guerin vector candidate vaccine for human immunodeficiency virus type 1 in small animals.

NLM AIDSLINE Protective immune responses induced by secretion of a chimeric soluble protein from a recombinant Mycobacterium bovis bacillus Calmette-Guerin vector candidate vaccine for human immunodeficiency virus type 1 in small animals. Honda M; Matsuo K; Nakasone T; Okamoto Y; Yoshizaki H; Kitamura K;
February 28, 1996

Proc Natl Acad Sci U S A. 1995 Nov 7;92(23):10693-7. Unique Identifier : A recombinant Mycobacterium bovis bacillus Calmette-Guerin (BCG) vector-based vaccine that secretes the V3 principal neutralizing epitope of human immunodeficiency virus (HIV) could induce immune response to the epitope and prevent the viral infection. By using the Japanese consensus sequence of HIV-1, we successfully constructed chimeric protein secretion vectors by selecting an appropriate insertion site of a carrier protein and established the principal neutralizing determinant (PND)-peptide secretion system in BCG. The recombinant BCG (rBCG)-inoculated guinea pigs were initially screened by delayed-type hypersensitivity (DTH) skin reactions to the PND peptide, followed by passive transfer of the DTH by the systemic route. Further, immunization of mice with the rBCG resulted in induction of cytotoxic T lymphocytes. The guinea pig immune antisera showed elevated titers to the PND peptide and neutralized HIVMN, and administration of serum IgG from the vaccinated guinea pigs was effective in completely blocking the HIV infection in thymus/liver transplanted severe combined immunodeficiency (SCID)/hu or SCID/PBL mice. In addition, the immune serum IgG was shown to neutralize primary field isolates of HIV that match the neutralizing sequence motif by a peripheral blood mononuclear cell-based virus neutralization assay. The data support the idea that the antigen-secreting rBCG system can be used as a tool for development of HIV vaccines. Amino Acid Sequence Animal Antibodies, Viral/BLOOD AIDS Vaccines/IMMUNOLOGY Base Sequence Enzyme-Linked Immunosorbent Assay Genetic Vectors Guinea Pigs Human HIV Envelope Protein gp120/IMMUNOLOGY HIV Infections/PREVENTION & CONTROL HIV-1/IMMUNOLOGY Immunization, Passive Mice Mice, SCID Middle Age Molecular Sequence Data Mycobacterium bovis/GENETICS Neutralization Tests Peptide Fragments/IMMUNOLOGY Skin Tests Support, Non-U.S. Gov't T-Lymphocytes, Cytotoxic Vaccines, Synthetic/*IMMUNOLOGY Viral Proteins/SECRETION JOURNAL ARTICLE

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Photographs from A Day with HIV Now Online Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 ARIZONA: Routine Skin Testing Available Again at Tuberculosis Clinic Starting May 20 NORTH DAKOTA: Officials: 26 Tuberculosis Cases from Grand Forks Outbreak AUSTRALIA: HIV Rates Triple in the Northern Territory in Just 12 Months ARIZONA: Parsons Foundation Gives $3 Million to Southwest Center for HIV/AIDS UNITED STATES: Triple Therapy for Hepatitis C is Effective After Liver Transplantation, but Side-Effects Are Common CANADA: Nunavut Uses Comic Book to Do Sex Education NEW HAMPSHIRE: State Health Officials Urge Hepatitis Testing UNITED STATES: Hepatitis C Testing for People Born Between 1945 and 1965 People with HIV pay more for life insurance – if they can get it (South Africa)Uganda: Gov't Urged to Levy a Tax On Alcohol to Fund HIV No time to lose in the search for an HIV vaccine CALIFORNIA: Donation to Fund HPV Vaccines for Youth PENNSYLVANIA: Scientists Weaken HIV Infection in Immune Cells Using Synthetic Agents KENTUCKY: Northern Kentucky Health Department Ready to Give Low-Cost Hepatitis B Vaccines to Adults Scientists Develop Experimental Vaccine Against Heroin NanoPass Technologies Supports a CDC-Sponsored Phase 3 Study of Polio Vaccine in Infants as Part of its Global Health Initiative 2012 US medicine sales show shifts by drug type Drugmakers, health groups bring poor girls vaccine GLOBAL: Cancer Vaccines Get a Price Cut in Poor Nations WISCONSIN: Cancer Linked to Oral Sex Increasing; Milwaukee Seeks to Educate, Promote Vaccines
Information in this article was accurate in February 28, 1996. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.